IP Library Assignment 017675/0384
Patent Assignment
Reel/Frame 017675/0384

Release of Security Interest

Recorded: 2006-05-25 Pages: 23
Assignor
LEHMAN COMMERICAL PAPER INC.
Executed: 2006-05-24
Assignee
MEDPOINTE HEALTHCARE INC.
265 DAVIDSON AVENUE, SUITE 300, SOMERSET, NEW JERSEY, 08873-4120
Covered Properties (42)
Weight Transfer Roller Apparatus
Patent: 4,382,637 →
Application: 06/124,534 →
Synthesis of B-((2-Methylpropoxy)Methyl)-N-Phenyl-N-(Phenyl)-1- Pyrrolidineethanamine
Patent: 4,620,015 →
Application: 06/521,895 →
Synthesis of 2-Phenyl - 1,3-Propanediol
Patent: 4,868,327 →
Application: 07/057,457 →
Combined Container and Closure
Patent: 332,215 →
Application: 07/254,533 →
Conversion of Diethyl Phenylmalonate to 2-Phenyl-1,3-Propanediol
Patent: 4,982,016 →
Application: 07/361,888 →
Reduction of Diethyl Phenylmalonate to 2-Phenyl-1,3-Propanediol
Patent: 5,091,595 →
Application: 07/362,891 →
Synthesis of 2-Phenyl-1,3-Propanediol
Patent: 5,072,056 →
Application: 07/412,769 →
Method for the Prevention and Control of Epileptic Seizure
Patent: 4,978,680 →
Application: 07/412,964 →
Azelastine and Its Salts Used to Combat Psoriasis
Patent: 5,110,814 →
Application: 07/458,350 →
Method for the Prevention and Control of Hypoxic Damage Resulting from Cerebral Ischemic Events
Patent: 5,055,489 →
Application: 07/518,892 →
Azelastine Containing Medicaments
Patent: 5,164,194 →
Application: 07/551,644 →
Method for the Prevention and Control of Epileptic Seizure Associated with Complex Partial Seizures
Patent: 5,082,861 →
Application: 07/624,041 →
Method of Treating Inflammatory Disorders and Psoriasis with Salts of Azelastine
Patent: 5,086,050 →
Application: 07/652,986 →
Cephalosporin Derivatives
Patent: 5,232,918 →
Application: 07/653,149 →
Controlled Release Azelastine-Containing Pharmaceutical Compositions
Patent: 5,271,946 →
Application: 07/865,769 →
Method for the Prevention and Control of Epileptic Seizure Associated with Lennox-Gastaut Syndrome
Patent: 5,292,772 →
Application: 07/966,964 →
Method for Treating and Controlling the Symptoms of Neurodegenerative Disease and Neuropsychopharmacological Disorders
Patent: 5,256,690 →
Application: 07/966,965 →
Method to Control the Intake of Food
Patent: 5,290,808 →
Application: 07/973,114 →
Device for Collection and Processing of Biological Samples
Patent: 5,316,731 →
Application: 07/973,734 →
Assay Using an Absorbent Material
Patent: 5,573,919 →
Application: 08/066,627 →
Methods for the Prevention and Control of Cellular Damage Resulting from Coronary Artery Occlusion-Reperfusion
Patent: 5,462,966 →
Application: 08/138,128 →
Sleep Therapy Package
Patent: 5,351,819 →
Application: 08/165,385 →
Sleep Therapy Package
Patent: 5,377,841 →
Application: 08/165,386 →
Pharmaceutical Compositions Containing 3-Iodo-1,2-Propanediol Having Mucolytic Activity
Patent: 5,723,501 →
Application: 08/754,611 →
Antihistamine Compositions
Application: 09/209,618 →
Publication: US 2001/0011104
Compositions and Methods for Treating Infections of the Air
Patent: 6,350,742 →
Application: 09/266,056 →
Method and Compositions for the Control or Eradication of Helicobacter Pylori
Patent: 6,555,534 →
Application: 09/266,095 →
Antihistaminic/Decongestant Compositions
Patent: 6,287,597 →
Application: 09/267,826 →
Decongestant/Antihistaminic Compositions
Patent: 6,037,358 →
Application: 09/275,121 →
Use of Taurolidine for Treatment of Leukemias
Patent: 6,303,596 →
Application: 09/424,426 →
Compositions and Methods for Treating Blood
Patent: 6,608,051 →
Application: 09/522,811 →
For Spermicidal and viricidal compositions
Patent: 6,302,108 →
Application: 09/523,029 →
Compositions and methods for the management of crohn's disease
Patent: 6,251,896 →
Application: 09/535,477 →
Antihistaminic/antitussive compositions
Patent: 6,306,904 →
Application: 09/625,422 →
Antitussive/Antihistaminic Compositions
Patent: 6,566,396 →
Application: 09/727,042 →
Publication: US 2002/0099021
Therapy pack
Application: 09/729,230 →
Publication: US 2002/0066691
Methods of Treating Tumors with Taurolidine
Patent: 6,521,616 →
Application: 09/730,666 →
Publication: US 2002/0052366
Use of Taurolidine to Treat Tumors
Patent: 6,429,224 →
Application: 09/730,923 →
Publication: US 2002/0111345
Use of a Methylol-Containing Compound to Treat Tumors
Patent: 6,964,959 →
Application: 09/731,214 →
Publication: US 2002/0049200
Antitussive/Antihist Aminic/Decongestant Compositions
Patent: 6,417,206 →
Application: 09/771,130 →
Truck rail cap system
Patent: 6,286,884 →
Application: 09/772,092 →
Dispenser Bottle
Patent: 447,419 →
Application: 29/123,685 →
Related Assignments (20)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 20, 1996
From: SOFIA, R. DUANE
To: CARTER-WALLACE, INC.
Reel/Frame 008317/0498 →
Assignment of Assignor's Interest Jul 28, 1997
From: ASTA PHARMA AKTIENGESELLSCHAFT
To: ASTA MEDICA AKTIENGESELLSCHAFT
Reel/Frame 008613/0535 →
Security Agreement Oct 24, 2001
From: MEDPOINT INC.; MCC ACQUISITION SUB CORPORATION; MCC MERGER SUB CORPORATION
To: LEHMAN COMMERCIAL PAPER INC.
Reel/Frame 012530/0854 →
Assignment of Assignor's Interest Sep 10, 2002
From: VIATRIS GMBH & CO. KG
To: MEDPOINTE HEALTHCARE, INC.
Reel/Frame 013269/0141 →
Change of Name Oct 21, 2002
From: ASTA MEDICA AG
To: VIATRIS GMBH & CO. KG
Reel/Frame 013386/0851 →
Security Interest May 6, 2003
From: INVERNESS MEDICAL SWITZERLAND GMBH; WAMPOLE LABORATORIES, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 014560/0001 →
Security Interest Oct 8, 2003
From: MEDPOINTE INC.; MCC ACQUISITION SUB CORPORATION; MCC MERGER SUB CORPORATION
To: LEHMAN COMMERCIAL PAPER, INC.
Reel/Frame 014567/0804 →
Change of Name Jan 7, 2004
From: CARTER-WALLACE, INC.
To: MEDPOINTE HEALTHCARE INC.
Reel/Frame 014235/0893 →
Assignment of Assignor's Interest Jan 9, 2004
From: MEDPOINTE HEALTHCARE, INC.
To: INVERNESS MEDICAL SWITZERLAND GMBH
Reel/Frame 014242/0807 →
Change of Name Jul 12, 2005
From: CARTER-WALLACE, INC.
To: MEDPOINTE HEALTHCARE INC.
Reel/Frame 016245/0386 →
Change of Name Jul 27, 2005
From: CARTER-WALLACE, INC.
To: MEDPOINTE HEALTHCARE INC.
Reel/Frame 016309/0625 →
Change of Name Aug 31, 2005
From: ASTA PHARMA AKTIENGESELLSCHAFT
To: ASTA MEDICA AKTIENGESELLSCHAFT
Reel/Frame 016470/0610 →
Assignment of Assignor's Interest Dec 15, 2005
From: SOFIA, ROBERT D.
To: MEDPOINTE HEALTHCARE INC.
Reel/Frame 016891/0953 →
Partial Release of Security Interest in Patents May 4, 2006
From: LEHMAN COMMERCIAL PAPER, INC.
To: MEDPOINTE INC.; THE CPI DEVELOPMENT CORPORATION; MEDPOINTE HEALTHCARE, INC.
Reel/Frame 017564/0981 →
Assignment of Assignor's Interest May 16, 2006
From: SOFIA, ROBERT D.
To: MEDPOINTE HEALTHCARE INC.
Reel/Frame 017619/0803 →
Security Agreement Jun 6, 2006
From: MEDPOINTE HEALTHCARE INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION
Reel/Frame 017730/0008 →
Change of Name Aug 30, 2006
From: CARTER-WALLACE, INC.
To: MEDPOINTE HEALTHCARE INC.
Reel/Frame 018184/0549 →
Change of Name Jul 22, 2008
From: MEDPOINTE HEALTHCARE INC.
To: MEDA PHARMACEUTICALS INC.
Reel/Frame 021266/0524 →
Change of Name Aug 25, 2008
From: MEDPOINTE HEALTHCARE INC.
To: MEDA PHARMACEUTICALS INC.
Reel/Frame 021428/0945 →
Assignment of Assignor's Interest Aug 25, 2008
From: SOFIA, ROBERT D.
To: MEDPOINTE HEALTHCARE INC.
Reel/Frame 021428/0814 →